|
||||
|
||||
|
![]() The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables, therapeutic workshops, fireside chats, company presentations, and One-on-One Partnering™ meetings. Overall attendance was up 28 percent, and investor attendance was up 14 percent over last year. |
![]() |
||
|
![]() |
02.10.14 11.18.13 Overhead at #BIF13. 'Can U believe we're still standing at the podium and pitching after all these years? Where did we go wrong?" — @ldtimmerman Paul Hastings: we have potential to improve in industry w/ more data transparency abt drug failures. #BIF13 Not a popular line in pharma —@ldtimmerman Orphan approach will be sustainable, says Esperion's Andreach, if "It's the right patient with the right drug for the right disease." #BIF13 —@BioWorld Not investing in NIH is silly, stupid and industry should be active, vocal and concerned about cuts. - Borisy #BIF13 — @Rrleuty_Biotech Primary care panel weighs in on ACA. Its impact will be "evolutionary rather than revolutionary," says NEA's Mathers. #BIF13 — @BioWorld Good stuff @IAmBiotech: here's a great summary from the plenary http://ow.ly/pEsZO — @IamBiotech Jan Lundberg: Bright people like to be around other bright people. You must have high standards. Give people freedom to operate, fail #BIF13 — @ldtimmerman |
![]() |
![]() |
![]() |
|
||||
© 2013 Biotechnology Industry Organization. All rights reserved About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising |
||||
![]() |